Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA

BACKGROUND: Adverse Drug Reactions (ADRs) are of great public health concern. FDA-approved drug labeling summarizes ADRs of a drug product mainly in three sections, i.e., Boxed Warning (BW), Warnings and Precautions (WP), and Adverse Reactions (AR), where the severity of ADRs are intended to decreas...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMC Bioinformatics
Glavni autori: Wu, Leihong, Ingle, Taylor, Liu, Zhichao, Zhao-Wong, Anna, Harris, Stephen, Thakkar, Shraddha, Zhou, Guangxu, Yang, Junshuang, Xu, Joshua, Mehta, Darshan, Ge, Weigong, Tong, Weida, Fang, Hong
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2019
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6419320/
https://ncbi.nlm.nih.gov/pubmed/30871458
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12859-019-2628-5
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items